phase 2 trial shows improvements in pulmonary exacerbations in cystic fibrosis patients
Published 6 years ago • 65 plays • Length 4:11Download video MP4
Download video MP3
Similar videos
-
3:12
results of phase 2 trial showing improvements in pulmonary exacerbations in cystic fibrosis
-
2:39
pulmonary exacerbations and cystic fibrosis
-
3:06
novel therapy for cystic fibrosis completes phase 2 trial
-
2:39
cystic fibrosis and pulmonary exacerbations
-
3:49
cystic fibrosis and rare inflammatory diseases
-
3:18
anti-protease levels in cf: lung function, recovery from pulmonary exacerbations & gender
-
1:12:58
nacfc 2020 | s18: targeting infection during pulmonary exacerbation management
-
1:56:15
nacfc 2021 | w27: cystic fibrosis pulmonary potpourri: effect of modulators and more
-
1:28:12
nacfc 2021 | w20: update on modulators
-
1:36:24
nacfc 2022 | w02: pulmonary pot pourri
-
0:29
pulmonary exacerbations and iv antibiotics - ecysticfibrosis review #shorts #cysticfibrosis
-
1:39
clinical trial: bms-986278 for pulmonary fibrosis (nct04308681)
-
0:54
challenges of diagnosing patients for pap and lung infection in cystic fibrosis
-
47:12
pulmonary exacerbations in the era of highly effective cftr modulators - d.b. sanders, md, ms
-
2:00:17
nacfc 2021 | s21: biomarkers & trial designs for novel cystic fibrosis therapies
-
1:01
did you know… what a pulmonary exacerbation is?
-
2:00:37
nacfc 2021 | s28: clinical advancements in modulator therapy
-
1:16:06
nacfc 2020 | s27: challenges of precision medicine in cystic fibrosis
-
1:34:32
nacfc 2020 | discipline group 6: challenging pharmacotherapy issues across the cf continuum of care